Email Address
info@sema.bio
This product is intended for research and development use only.
$395.00
This package includes 5 vials of 10 mg tirzepatide (lyophilized powder) and 11 mL of sterile solvent for reconstitution. Designed for multiple weeks of use, depending on your dosing schedule.
Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide is a dual GIP and GLP-1 receptor agonist. This innovation offers:
| Week | Dose (mg/week) | Total mg Used |
|---|---|---|
| 1-4 | 2.5 mg | 10 mg |
| 5-8 | 5 mg | 20 mg |
| 9-12 | 7.5 mg | 30 mg |
| 13-16 | 10 mg | 40 mg |
| 17+ | 12.5 mg or 15 mg (optional) | 50-60 mg |
Most users stay at 5 or 7.5 mg/week as their maintenance dose, which provides consistent results with minimal side effects. Higher doses (10–15 mg) are optional and should be evaluated individually.
Laboratory reports demonstrating 99% purity of semaglutide at the link.
Learn how to reconstitute semalguitde in the laboratory in our Reconstitution Guidelines.
Learn more about semaglutide in our Semaglutide FAQ.
While we make a reasonable effort to ensure the quality, accuracy, and safety of the content on our website, it is important to state that it is provided for general information purposes only and does not constitute medical advice. The content on this website, including text, images, and other content, is not intended to replace a consultation with an appropriately qualified medical practitioner.
SEMA.bio does not provide medical advice. Always consult your healthcare provider about possible interactions, contraindications, and allergies before starting any new supplement or medication.
Individual weight loss results may vary.
Products offered on this website are not approved by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. Any improper use, including but not limited to the unauthorized handling, storage, or administration of these products, is the sole responsibility of the purchaser. This website and its product offerings are not associated, connected with or endorsed by Nоvо Nоrdіsk A/S in any manner.
